BPC-157 + TB-500. The recovery stack serious athletes use.

Two peptides with overlapping but distinct mechanisms. Together, they cover every phase of tissue repair.

You're on the list. We'll notify you the moment these peptides become available.

BPC-157 is currently classified as FDA Category 2 and cannot be legally compounded for routine patient use. We will notify you the moment this changes and we are able to offer it.

THE SCIENCE

Two mechanisms. One complete protocol.

BPC-157 drives localized repair — angiogenesis, collagen synthesis, cytokine reduction. TB-500 drives systemic mobilization — actin upregulation, progenitor cell migration, and the transition from inflammation to proliferation.

In orthopedic medicine, we describe healing in three phases: inflammation, proliferation, and remodeling. The Wolverine Protocol addresses all three. BPC-157 targets the site. TB-500 signals the system. Together, they do what neither accomplishes alone.

— Anup Pradhan, MD

Be first in line.

We'll notify you the moment BPC-157 becomes available.

You're on the list. We'll notify you the moment these peptides become available.